Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Современные возможности диагностики и лечения бактериального вагиноза
Современные возможности диагностики и лечения бактериального вагиноза
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001–2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 2007; 109 (1): 114–20.
2. Donders G. Diagnosis and Management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review. Obstet Gynecol Surv 2010; 65 (7): 462–73.
3. Xia Zhou, Rebacca M, Pawel G et al. Recent Advances in Understanding the Microbiology of the Female Reproductive Tract and the Causes of Premature. Birth Infect Dis Obstet Gynecol 2010; 2010: 737425.
4. Swidsinski A, Mendling W et al. Adherent Biofilms in Bacterial Vaginosis. Obstet Gynecol 2005; 106 (5): 1016–23.
5. Swidsinski A, Mendling W et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obst Gynecol 2008; 198: 97.e1-6.
6. Hay P. Recurrent bacterial vaginosis. Curr Infect Dis Rep 2000; 2: 506–12.
7. Swidsinski A, Mendling W et al. Adherent Biofilms in Bacterial Vaginosis. Obstet Gynecol 2005; 106 (5): 1016–23.
8. Togni G, Battini V, Bulgheroni A et al. In vitro activity of nifuratel on vaginal bacteria: could it be a good candidate for the treatment of bacterial vaginosis? Antimicrob Agents Chemother 2011; 55: 2490–2.
9. Zhou X, Bent SJ, Schneider MG et al. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 2004; 150: 2565–73.
10. Marconi C, Cruciani F, Vitali B, Donders G. Correlation of Atopobium vaginae amount with bacterial vaginosis markers.
J Lower Genital Tract Disease 2012; 16 (2):127–32.
11. Workowski KA. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR. 2010. 59 (RR12); p. 1–110. URL: http://www.cdc.gov/mmwr; Sherrard J. European (IUSTI/WHO) Guideline on the Management of Vaginal Discharge, 2011. Sherrard J, Donders G, White D. Epub ahead of print. URL: http://www.iusti.ru
12. Amsel R, Totten PA, Spiegel CA et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14–22.
13. Fredricks DN, Fiedler TL, Marazzo JM. Molecular indentification of bacterial vaginosis associated with bacterial vaginosis.
N Engl J Med 2005; 353: 1899.
14. Polatti F, Rampino M, Magnani P, Mascarucci P. Vaginal pH-lowering effect of locally applied vitamin C in subjects with high vaginal pH. Gynecol Endocrinol 2006; 22 (4): 230–4.
15. Petersen EE, Genet M, Caserini M, Palmieri R. Efficacy of vitamin C vaginal tablets in the treatment of bacterial vaginosis: a randomised, double blind, placebo controlled study. Arzneimittelforschung 2011;61(4):260-265.
2. Donders G. Diagnosis and Management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review. Obstet Gynecol Surv 2010; 65 (7): 462–73.
3. Xia Zhou, Rebacca M, Pawel G et al. Recent Advances in Understanding the Microbiology of the Female Reproductive Tract and the Causes of Premature. Birth Infect Dis Obstet Gynecol 2010; 2010: 737425.
4. Swidsinski A, Mendling W et al. Adherent Biofilms in Bacterial Vaginosis. Obstet Gynecol 2005; 106 (5): 1016–23.
5. Swidsinski A, Mendling W et al. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obst Gynecol 2008; 198: 97.e1-6.
6. Hay P. Recurrent bacterial vaginosis. Curr Infect Dis Rep 2000; 2: 506–12.
7. Swidsinski A, Mendling W et al. Adherent Biofilms in Bacterial Vaginosis. Obstet Gynecol 2005; 106 (5): 1016–23.
8. Togni G, Battini V, Bulgheroni A et al. In vitro activity of nifuratel on vaginal bacteria: could it be a good candidate for the treatment of bacterial vaginosis? Antimicrob Agents Chemother 2011; 55: 2490–2.
9. Zhou X, Bent SJ, Schneider MG et al. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 2004; 150: 2565–73.
10. Marconi C, Cruciani F, Vitali B, Donders G. Correlation of Atopobium vaginae amount with bacterial vaginosis markers.
J Lower Genital Tract Disease 2012; 16 (2):127–32.
11. Workowski KA. Sexually Transmitted Diseases Treatment Guidelines, 2010. MMWR. 2010. 59 (RR12); p. 1–110. URL: http://www.cdc.gov/mmwr; Sherrard J. European (IUSTI/WHO) Guideline on the Management of Vaginal Discharge, 2011. Sherrard J, Donders G, White D. Epub ahead of print. URL: http://www.iusti.ru
12. Amsel R, Totten PA, Spiegel CA et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74: 14–22.
13. Fredricks DN, Fiedler TL, Marazzo JM. Molecular indentification of bacterial vaginosis associated with bacterial vaginosis.
N Engl J Med 2005; 353: 1899.
14. Polatti F, Rampino M, Magnani P, Mascarucci P. Vaginal pH-lowering effect of locally applied vitamin C in subjects with high vaginal pH. Gynecol Endocrinol 2006; 22 (4): 230–4.
15. Petersen EE, Genet M, Caserini M, Palmieri R. Efficacy of vitamin C vaginal tablets in the treatment of bacterial vaginosis: a randomised, double blind, placebo controlled study. Arzneimittelforschung 2011;61(4):260-265.
Авторы
Г.Р.Байрамова
ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздрава РФ, Москва
ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздрава РФ, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.